Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism?

被引:27
作者
Hu, Jing [1 ]
Liu, Zhiqiang [2 ]
Wang, Xipeng [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Gynecol, Shanghai 200092, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Anesthesiol, Shanghai 200092, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; ACID-BINDING PROTEIN; TGF-BETA; P53-INDUCIBLE REGULATOR; CELL INVASION; P53; EXPRESSION; SMAD; GROWTH; EMT;
D O I
10.1016/j.mehy.2013.06.009
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
TP53 (Tumor Protein 53, previously known as p53) is probably the best known of all tumor suppressor genes, and is mutated in nearly all (96%) high-grade serous ovarian cancer (HGS-OvCa), which is the most common histopathological type of epithelial ovarian cancer (EOC). Recently, TP53 is found to involve in regulating cell metabolic pathways besides its classical tumor suppressive functions. In addition, emerging evidence suggests that mutant TP53 is associated with cancer metastasis. Through summarizing and comparing the roles of wild-type TP53 and mutant TP53 in the progression of various types of cancer, we hypothesize that mutant TP53 in HGS-OvCa cells interacts with sterol regulatory element-binding proteins (SREBPs) and guanidinoacetate N-methyltransferase (GAMT), leading to increased gene expression of key enzymes involved in fatty acids (FAs) and cholesterol biosynthesis and the inhibition of fatty acid oxidation (FAO), thus promotes lipid anabolism to accelerate tumor growth and progression. Elevated platelet number in patients' tumor microenvironment results in increased TGF-beta production. Then, TGF-beta acts in concert with mutant TP53 to promote HGS-OvCa metastasis by assembling a mutant-TP53/p63/Smads protein complex, in which p63's functions as metastasis suppressor are antagonized, and by enhancing the activities of the Slug/Snail and Twist families to drive induce EMT-like transition. Then adipocyte-derived IL-8 facilitates the metastasis of transformative cancer cells to abdominal adipose tissue (e.g., omentum). Once metastasis is established, mutant TP53 together with adipocyte-derived IL-8 upregulates Fatty acid-binding protein 4 (FABP4) expression and then promotes FAs absorption from adipocytes to support rapid tumor growth in adipocyte-rich metastatic environments. In summary, these indicate that mutant TP53 may play determinant roles in the progression of HGS-OvCa. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:515 / 520
页数:6
相关论文
共 61 条
[1]   A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis [J].
Adorno, Maddalena ;
Cordenonsi, Michelangelo ;
Montagner, Marco ;
Dupont, Sirio ;
Wong, Christine ;
Hann, Byron ;
Solari, Aldo ;
Bobisse, Sara ;
Rondina, Maria Beatrice ;
Guzzardo, Vincenza ;
Parenti, Anna R. ;
Rosato, Antonio ;
Bicciato, Silvio ;
Balmain, Allan ;
Piccolo, Stefano .
CELL, 2009, 137 (01) :87-98
[2]   Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary [J].
Ahmed, Ashour Ahmed ;
Etemadmoghadam, Dariush ;
Temple, Jillian ;
Lynch, Andy G. ;
Riad, Mohamed ;
Sharma, Raghwa ;
Stewart, Colin ;
Fereday, Sian ;
Caldas, Carlos ;
DeFazio, Anna ;
Bowtell, David ;
Brenton, James D. .
JOURNAL OF PATHOLOGY, 2010, 221 (01) :49-56
[3]  
Bai ZF, 2013, CANC RES
[4]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[5]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[6]   The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors [J].
Bolós, V ;
Peinado, H ;
Pérez-Moreno, MA ;
Fraga, MF ;
Esteller, M ;
Cano, A .
JOURNAL OF CELL SCIENCE, 2003, 116 (03) :499-511
[7]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
[8]   Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data [J].
Coleman, M. P. ;
Forman, D. ;
Bryant, H. ;
Butler, J. ;
Rachet, B. ;
Maringe, C. ;
Nur, U. ;
Tracey, E. ;
Coory, M. ;
Hatcher, J. ;
McGahan, C. E. ;
Turner, D. ;
Marrett, L. ;
Gjerstorff, M. L. ;
Johannesen, T. B. ;
Adolfsson, J. ;
Lambe, M. ;
Lawrence, G. ;
Meechan, D. ;
Morris, E. J. ;
Middleton, R. ;
Steward, J. ;
Richards, M. A. .
LANCET, 2011, 377 (9760) :127-138
[9]   Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways [J].
Davies, M ;
Robinson, M ;
Smith, E ;
Huntley, S ;
Prime, S ;
Paterson, I .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 95 (05) :918-931
[10]   Impact of statin therapy on survival in epithelial ovarian cancer [J].
Elmore, R. Geoffrey ;
Ioffe, Yevgeniya ;
Scoles, Daniel R. ;
Karlan, Beth Y. ;
Li, Andrew J. .
GYNECOLOGIC ONCOLOGY, 2008, 111 (01) :102-105